Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04095689
Title TAC Chemotherapy and Pembrolizumab Plus Interleukin-12 Gene Therapy and L-NMMA in Triple Negative Breast Cancer
Recruitment Suspended
Gender female
Phase Phase II
Variant Requirements No
Sponsors The Methodist Hospital System
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Houston Methodist Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field